Nomogram prediction for the involution of the ablation zone after radiofrequency ablation treatment in patients with low-risk papillary thyroid carcinoma

References

• Kitahara CS, Brenner AV. Thyroid cancer. New York: Oxford University Press; 2018.
   Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
   PubMed Web of Science ®Google Scholar
• Gabrichidze T, McHedlishvili I, Zhizhilashvili A, et al. Temporal trends of cervical cancer mortality in Georgia, 2011–2018. Georgian Med News. 2020;309:17–21.
   PubMedGoogle Scholar
• Alobuia W, Gillis A, Kebebew E. Contemporary management of anaplastic thyroid cancer. Curr Treat Options Oncol. 2020; 21(10):78.
   PubMed Web of Science ®Google Scholar
• Haddad RI, Nasr C, Bischoff L, et al. NCCN guidelines insights: thyroid carcinoma, version 2.2018. J Natl Compr Canc Netw. 2018;16(12):1429–1440.
   PubMed Web of Science ®Google Scholar
• Roman BR, Brito JP, Saucke MC, et al. National survey of endocrinologists and surgeons regarding active surveillance for low-risk papillary thyroid cancer. Endocr Pract. 2021;27(1):1–7.
   PubMed Web of Science ®Google Scholar
• Solis-Pazmino P, Salazar-Vega J, Lincango-Naranjo E, et al. Thyroid cancer overdiagnosis and overtreatment: a cross-sectional study at a thyroid cancer referral center in Ecuador. BMC Cancer. 2021;21(1):42.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016;12(11):646–653.
   PubMed Web of Science ®Google Scholar
• Sanabria A, Kowalski LP, Shah JP, et al. Growing incidence of thyroid carcinoma in recent years: factors underlying overdiagnosis. Head Neck. 2018;40(4):855–866.
   PubMed Web of Science ®Google Scholar
• Choi Y, Jung SL. Efficacy and safety of thermal ablation techniques for the treatment of primary papillary thyroid microcarcinoma: a systematic review and meta-analysis. Thyroid. 2020;30(5):720–731.
   PubMed Web of Science ®Google Scholar
• Yan L, Lan Y, Xiao J, et al. Long-term outcomes of radiofrequency ablation for unifocal low-risk papillary thyroid microcarcinoma: a large cohort study of 414 patients. Eur Radiol. 2021;31(2):685–694.
   PubMed Web of Science ®Google Scholar
• Xiao J, Zhang Y, Zhang M, et al. Ultrasonography-guided radiofrequency ablation vs. surgery for the treatment of solitary T1bN0M0 papillary thyroid carcinoma: a comparative study. Clin Endocrinol. 2021;94(4):684–691.
   PubMed Web of Science ®Google Scholar
• Sanabria A. Experience with active surveillance of thyroid low-risk carcinoma in a developing country. Thyroid. 2020;30(7):985–991.
   PubMed Web of Science ®Google Scholar
• Hegedus L, Frasoldati A, Negro R, et al. European thyroid association survey on use of minimally invasive techniques for thyroid nodules. Eur Thyroid J. 2020;9(4):194–204.
   PubMed Web of Science ®Google Scholar
• Cho SJ, Baek SM, Lim HK, et al. Long-term follow-up results of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: more than 5-year follow-up for 84 tumors. Thyroid. 2020;30(12):1745–1751.
   PubMed Web of Science ®Google Scholar
• Lin W-C, Kan N-N, Chen H-L, et al. Efficacy and safety of single-session radiofrequency ablation for benign thyroid nodules of different sizes: a retrospective study. Int J Hyperthermia. 2020;37(1):1082–1089.
   PubMed Web of Science ®Google Scholar
• Chung SR, Baek JH, Choi YJ, et al. Efficacy of radiofrequency ablation for recurrent thyroid cancer invading the airways. Eur Radiol. 2021;31(4):2153–2160.
   PubMed Web of Science ®Google Scholar
• Tong M, Li S, Li Y, et al. Efficacy and safety of radiofrequency, microwave and laser ablation for treating papillary thyroid microcarcinoma: a systematic review and meta-analysis. Int J Hyperthermia. 2019;36(1):1278–1286.
   PubMed Web of Science ®Google Scholar
• Lee GM, You JY, Kim HY, et al. Successful radiofrequency ablation strategies for benign thyroid nodules. Endocrine. 2019;64(2):316–321.
   PubMed Web of Science ®Google Scholar
• Chung SR, Baek JH, Choi YJ, et al. Longer-term outcomes of radiofrequency ablation for locally recurrent papillary thyroid cancer. Eur Radiol. 2019;29(9):4897–4903.
   PubMed Web of Science ®Google Scholar
• Kong QF, Lv B, Wang B, et al. Association of von Willebrand factor (vWF) expression with lymph node metastasis and hemodynamics in papillary thyroid carcinoma. Eur Rev Med Pharmacol Sci. 2020;24(5):2564–2571.
   PubMed Web of Science ®Google Scholar
• Yan L, Luo Y, Zhang Y, et al. The clinical application of Core-Needle biopsy after radiofrequency ablation for low-risk papillary thyroid microcarcinoma: a large cohort of 202 patients study. J Cancer. 2020;11(18):5257–5263.
   PubMed Web of Science ®Google Scholar
• Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208.
   PubMed Web of Science ®Google Scholar
• Zhang M, Luo Y, Zhang Y, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study. Thyroid. 2016;26(11):1581–1587.
   PubMed Web of Science ®Google Scholar
• Trimboli P, Deandrea M. Treating thyroid nodules by radiofrequency: is the delivered energy correlated with the volume reduction rate? A pilot study. Endocrine. 2020;69(3):682–687.
   PubMed Web of Science ®Google Scholar
• Deandrea M, Trimboli P, Mormile A, et al. Determining an energy threshold for optimal volume reduction of benign thyroid nodules treated by radiofrequency ablation. Eur Radiol. 2021;31(7):5189–5197.
   PubMed Web of Science ®Google Scholar
• Deandrea M, Garino F, Alberto M, et al. Radiofrequency ablation for benign thyroid nodules according to different ultrasound features: an Italian multicentre prospective study. Eur J Endocrinol. 2019;180(1):79–87.
   PubMed Web of Science ®Google Scholar
• Heerink WJ, Solouki AM, Vliegenthart R, et al. The relationship between applied energy and ablation zone volume in patients with hepatocellular carcinoma and colorectal liver metastasis. Eur Radiol. 2018;28(8):3228–3236.
   PubMed Web of Science ®Google Scholar
• Pan Q, Yuan T, Ding Q. Clinical value of matrix metalloproteinase-2 and -9 in ultrasound-guided radiofrequency ablation treatment for papillary thyroid carcinoma. J Int Med Res. 2020;48(8):300060520917581.
   PubMed Web of Science ®Google Scholar
• Weiskopf D, Weinberger B, Grubeck-Loebenstein B. The aging of the immune system. Transpl Int. 2009;22(11):1041–1050.
   PubMed Web of Science ®Google Scholar
• Ferreira LB, Gimba E, Vinagre J, et al. Molecular aspects of thyroid calcification. Int J Mol Sci. 2020;21(20):7718.
   Web of Science ®Google Scholar
• Ha J, Lee J, Jo K, et al. Calcification patterns in papillary thyroid carcinoma are associated with changes in thyroid hormones and coronary artery calcification. J Clin Med. 2018;7(8):183.
   PubMed Web of Science ®Google Scholar